Teva Pharmaceutical Industries reported $12.45B in Current Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Abbvie ABBV:US $ 26509M 1419M
Aerie Pharmaceuticals AERI:US $ 316.97M 38.68M
Amarin AMRN:US $ 772.62M 106.11M
Amgen AMGN:US $ 18520M 865M
AstraZeneca AZN:LN 22.65B 3.6B
Biogen BIIB:US $ 7915.9M 59.4M
Bristol Myers Squibb BMY:US $ 30121M 3141M
Coherus Biosciences CHRS:US $ 512.44M 89.88M
Eli Lilly And LLY:US $ 16964.7M 1487.7M
Emergent Biosolutions EBS:US $ 1100.3M 171.8M
Endo International Ordinary Shares ENDP:US $ 2492.79M 221.79M
Gilead Sciences GILD:US $ 12629M 2143M
GlaxoSmithKline GSK:LN 28.99B 10.31B
Henry Schein HSIC:US $ 3830M 14.04M
Horizon Pharma HZNP:US $ 2947.73M 147.96M
JAZZ PHA JAZZ:US $ 2500.86M 110.48M
Lannett LCI:US $ 318.7M 15.91M
Merk MRK:US $ 31184M 918M
Novartis NOVN:VX 37.24B 8.48B
Pacira Pharmaceuticals PCRX:US $ 667.02M 199.03M
Patterson Companies PDCO:US $ 1790.43M 9M
Perrigo Ordinary Shares PRGO:US $ 3935.5M 75.6M
Phibro Animal Health PAHC:US $ 546.48M 37.87M
Revance Therapeutics RVNC:US $ 285.33M 39.21M
Supernus Pharmaceuticals SUPN:US $ 568.52M 33.07M
Takeda 4502:JP Y 2593642M 115749M
Teva Pharmaceutical Industries TEVA:US $ 12451M 122M
Xeris Pharmaceuticals Inc XERS:US $ 177.55M 34.95M
Zoetis ZTS:US $ 6837M 93M